Nice fluff announcement to try stop the damage they have caused by the unnecessary CR. They have away instant profits. Now watch it drop to .16c
very poor decision
lost the trust of investors
- Forums
- ASX - By Stock
- VR1
- Ann: Vection TCV Growth Outperforms First Half Objective
Ann: Vection TCV Growth Outperforms First Half Objective, page-43
-
- There are more pages in this discussion • 123 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VR1 (ASX) to my watchlist
|
|||||
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $21.40M |
Open | High | Low | Value | Volume |
2.0¢ | 2.0¢ | 1.9¢ | $22.18K | 1.162M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 238918 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 190144 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 238918 | 0.019 |
8 | 1049882 | 0.018 |
2 | 455000 | 0.017 |
5 | 650000 | 0.016 |
4 | 624000 | 0.015 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 190144 | 2 |
0.021 | 1040373 | 10 |
0.022 | 1090770 | 8 |
0.023 | 449310 | 1 |
0.024 | 548207 | 5 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
VR1 (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online